Anocca AB provides services like Biotechnology, Immunotherapeutics, Drug Discovery, Drug Development, Immunology.
Anocca has raised €104M across 3 funding rounds from 11 investors, most recently a round in Aug 2025. Based in Södertälje, Sweden; active in Healthtech. Data as of 6 Aug 2026.
Timing: in window vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors |
|---|
| 2025-08-20 | Other | €39M | AMF,Existing Shareholders,Mellby Gård,new investors,Ramsbury Invest | View deal → |
| 2022-12-21 | Debt | €25M | European Investment Bank | View deal → |
| 2021-08-03 | Series B | €40M | Harald Mix,Mellby Gård,Michano,Nidoco,Ramsbury Invest,Robert Andreen+1 more | View deal → |
